In the conducted studies, complete tumor regression was obtained in benign tumors and partial regression was obtained in malignant tumors after the administration of tamoxifen and cyproterone acetate, which are pharmacological hormone receptor blockers. This evidence concerns the gene NR4A1 and cancer.